Ianalumab
- Generic Name
- Ianalumab
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 1929549-92-7
- Unique Ingredient Identifier
- ZN2GQ3II96
- Background
Ianalumab is under investigation in clinical trial NCT01930175 (Study of Efficacy and Safety of VAY736 in Patients With Pemphigus Vulgaris).
- Associated Conditions
- -
- Associated Therapies
- -
Biopsy Based Study to Understand Mechanism of Action of Ianalumab in Salivary Glands and Explore Relationships With Clinical Assessments.
- First Posted Date
- 2021-11-18
- Last Posted Date
- 2024-08-13
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 21
- Registration Number
- NCT05124925
- Locations
- 🇫🇷
Novartis Investigative Site, Brest, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath